HCA Healthcare, Inc. (HCA - Free Report) delivered first-quarter 2019adjusted earnings of $2.97 per share, surpassing the Zacks Consensus Estimate by 28.6%. Moreover, the bottom line shot up 27.5% year over year. This upside was backed by higher admissions and revenues.
HCA Healthcare generated revenues of $12.5 billion, beating the Zacks Consensus Estimate by 1.7%. The top line was also up 9.6% from the year-ago period.
Same facility admissions and equivalent admissions inched up 0.9% and 1.8%, each, in the quarter under review. Same facility revenue per equivalent admission grew 4.4%. Same facility inpatient surgeries slipped 0.3% against the same facility outpatient surgeries, which got nudged up 1.3%.Same facility revenue per equivalent admission rose 4.4% from the prior-year quarter.
In the first quarter, cash flow from operations totaled $974 million, down 24.1% year over year.
Expenses increased nearly 7.2% year over year to $9.9 billion.
Adjusted EBITDA totaled $2.5 billion, up 20% year over year.
As of Mar 31, 2019, HCA Healthcare ran 185 hospitals and around 2000 sites of care including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics.
HCA Healthcare, Inc. Price, Consensus and EPS Surprise
As of Mar 31, 2019, the company had cash and cash equivalents of about $531 million, total debt less net debt issuance of $31 billion and total assets of $43.4 billion, up 5.8%, down 3.2% and up 10.6%, respectively.
During the reported quarter, capital expenditures totaled $781 million excluding acquisitions.
Share Buyback and Dividend Update
HCA Healthcare has announced a quarterly cash dividend of 40 cents per share, payable Jun 28, 2019 to stockholders of record at the close of business on Jun 3, 2019.
In the quarter under consideration, the company bought back common stock for $278 million. As of Mar 31,2019, it had stock worth $1.9 billion remaining under its current repurchase authorization.
In the first quarter of 2019, the company closed the buyout of Mission Health for around $1.5 billion.
Guidance for 2019
Revenues of the company are now expected to range from $50.5 to $51.5 billion.
Adjusted EBITDA of the company is projected between $9.45 and $9.85 billion, up from the previous outlook of $9.35-$9.75 billion.
EPS is assumed to be $9.80-$10.40 per share, higher than the earlier projection of $9.60-$10.20.
Capital expenditures are still anticipated to be around $3.7 billion.
HCA Healthcare sports a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.
Among other players from the medical sector having reported first-quarter earnings so far, the bottom-line figures of Anthem Inc. (ANTM - Free Report) , Centene Corporation (CNC - Free Report) and UnitedHealth Group Inc. (UNH - Free Report) beat the respective Zacks Consensus Estimate.
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”
Click to get it free >>